| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 5, 1193-1200, Copyright © 1994 by American Society of Nephrology
REGULAR ARTICLES |
VE Torres, DK Mujwid, DM Wilson and KH Holley
Division of Internal Medicine and Nephrology, Mayo Clinic and Foundation, Rochester, MN 55905.
Cyst formation in conditions associated with increased renal ammoniagenesis (hypokalemia, distal renal tubular acidosis, renal mass reduction) and experimental links between increased ammoniagenesis and interstitial inflammation have suggested a role for ammonia in the pathogenesis of polycystic kidney disease (PKD). To explore this hypothesis, Han:SPRD rats, a PKD model that affects male more severely than female animals, have been used. Heterozygous cystic (Cy/+) and homozygous normal (+/+) male and female offspring of Cy/+ rats were divided at 3 wk of age into control groups drinking water and experimental groups drinking 300 mM NH4Cl, 300 mM KHCO3, 200 mM KHCO3, 200 mM KCl, 200 mM NaHCO3, or 200 mM NaCl. At 2 months of age, the rats were kept fasting from 8:00 p.m. to 8:00 a.m. in metabolic cages and urine samples were collected under mineral oil. The rats were then weighed and anesthetized for the collection of blood and kidneys. The administration of 300 mM NH4Cl, and to a lesser extent that of 200 mM NaCl, was accompanied by an increase in the urinary excretion of ammonia and aggravation of the renal cystic disease. On the other hand, the administration of 300 mM KHCO3, 200 mM KHCO3, or 200 mM NaHCO3 lowered the urinary excretion of ammonia and markedly reduced the severity of the cystic disease and interstitial inflammation. The administration of 300 mM KHCO3, and to a lesser extent that of 200 mM KHCO3, resulted in the precipitation of calcium phosphate in the medullary collecting ducts.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
L. M. Guay-Woodford Murine models of polycystic kidney disease: molecular and therapeutic insights Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1034 - F1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Maser, D. Vassmer, B. S. Magenheimer, and J. P. Calvet Oxidant Stress and Reduced Antioxidant Enzyme Protection in Polycystic Kidney Disease J. Am. Soc. Nephrol., April 1, 2002; 13(4): 991 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Obermuller, N. Morente, B. Kranzlin, N. Gretz, and R. Witzgall A possible role for metalloproteinases in renal cyst development Am J Physiol Renal Physiol, March 1, 2001; 280(3): F540 - F550. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. AUKEMA, I. HOUSINI, and J. M. RAWLING Dietary Soy Protein Effects on Inherited Polycystic Kidney Disease Are Influenced by Gender and Protein Level J. Am. Soc. Nephrol., February 1, 1999; 10(2): 300 - 308. [Abstract] [Full Text] |
||||
![]() |
M. R. Ogborn, N. Bankovic-Calic, C. Shoesmith, R. Buist, and J. Peeling Soy protein modification of rat polycystic kidney disease Am J Physiol Renal Physiol, March 1, 1998; 274(3): F541 - F549. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673